Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors [Phase 1, Phase 2]
A pediatric Phase 1/2 trial evaluating nivolumab in combination with metronomic chemotherapy for refractory/relapsing solid tumors; the stud…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors [Phase 1]
A first-in-human Phase 1 study to evaluate the safety and tolerability of VVD-159642 in participants with solid tumors; recruitment is ongoi…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating KK2260 in patients with advanced or metastatic solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers [Phase 1, Phase 2]
A clinical trial update describing STK-012 alone or in combination for advanced lung cancer and other solid tumors, currently recruiting in …
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors [Phase 1]
Open-label Phase 1 trial evaluating INV-1120 as a single agent and in combination with pembrolizumab in adults with advanced solid tumors; c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation [Phase 1]
AstraZeneca's Phase I/IIa study of AZD0022 in KRASG12D-mutant tumors has been terminated. The study enrolled adults with advanced solid tumo…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: CSF and Blood Plasma Liquid Biopsy in Patients With Metastatic Solid Tumours and CNS Metastases or no CNS Metastases [NA]
A clinical trial evaluating CSF and blood plasma liquid biopsy in patients with metastatic solid tumors, with and without brain metastases o…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation [Phase 2]
Phase II trial of tazemetostat in solid tumors harboring ARID1A mutations has been terminated.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Exploration Study of Molecular Biomarkers for Tumor-related Anxiety and Depression
A clinical trial exploring molecular biomarkers associated with tumor-related anxiety and depression in patients with solid tumor malignanci…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports that GI Innovation is studying GI-101 and GI-101A as single agents or in combination with pembrolizumab o…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating ETX-636 in adults with advanced solid tumors and advanced breast cancer; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California [NA]
This clinical trial entry describes a culturally informed patient navigation program aimed at reducing delays from diagnosis to treatment fo…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients [Phase 1, Phase 2]
An ongoing phase 1/2 pediatric trial examines safety and potential efficacy of a four-drug combination (cyclophosphamide, sorafenib, bevaciz…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Standardized Nutritional Management of Pediatric Patients With Solid Tumors [NA]
This clinical trial examines standardized nutritional management for pediatric patients with solid tumors. The study is currently recruiting…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Predicting Reactions and Effects of Drugs Immunotherapy and Complications Through Oncosafety (PREDICTO Clinical Study) [NA]
This entry describes the PREDICTO clinical study aimed at predicting reactions and complications from cancer immunotherapy, sponsored by Ass…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Reduced Intensity Haploidentical BMT for High Risk Solid Tumors [Phase 2]
Phase 2 trial investigating reduced-intensity haploidentical bone marrow transplantation for high-risk metastatic solid tumors; the study st…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors [Phase 1]
A Phase 1 study of D3L-001 as monotherapy in HER2-positive advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2026-03-13Clinical Trial Update: BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors [Phase 1]
A Phase 1 trial evaluating BGB-A3055 alone and in combination with tislelizumab for solid tumors was terminated.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001) [Phase 1]
A Phase 1 study (MK-0472-001) of MK-0472 in participants with advanced or metastatic solid tumors; the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their Spouses [NA]
This clinical trial update describes a program to help patients and spouses understand and manage the financial aspects of cancer care. The …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation. [Phase 1]
Phase 1 clinical trial to assess the pharmacokinetic interactions of multiple doses of rezatapopt with metformin, rosuvastatin, repaglinide,…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation [Phase 1, Phase 2]
A Phase 1/2 study of D3S-001 as a monotherapy or combination therapy in advanced solid tumors with KRAS p.G12C mutation is currently recruit…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Organotypic Platform for Therapeutic Investigation (OPTin) for Guiding Cancer Patients Treatment
Clinical trial update describing the OPTin organotypic platform to guide treatment decisions for patients with solid tumors/cancer, currentl…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors [Phase 1]
BeiGene is conducting a Phase 1 study of BG-T187 both alone and in combination with other agents for advanced solid tumors, and recruitment …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies [Phase 1, Phase 2]
A Phase 1/Phase 2 study of AZD9574 as a monotherapy and in combination with anti-cancer agents is underway in participants with advanced sol…